Rockwell Medical (RMTI) Total Current Liabilities (2010 - 2026)
Rockwell Medical (RMTI) reported Total Current Liabilities of $9.9 million for Q1 2026, down 11.93% on a YoY basis from $11.2 million in Q1 2025, and up 3.01% quarter-over-quarter from $9.6 million in Q4 2025.
Rockwell Medical (RMTI) Total Current Liabilities (2010 - 2026) Analysis & Trends
Rockwell Medical has reported Total Current Liabilities for 17 years, with the latest figure at $9.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 11.93% year-over-year to $9.9 million; the trailing twelve-month figure through Mar 2026 stood at $9.9 million (down 11.93% YoY), and the FY2025 full-year result was $9.6 million, down 32.01% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $9.9 million, up from $9.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $21.4 million in Q3 2023, with the low at $9.6 million in Q4 2025.
- Historically, Total Current Liabilities has averaged $15.0 million across 5 years, with a median of $14.9 million in 2024.
- The largest YoY upside for Total Current Liabilities was 74.46% in 2022 against a maximum downside of 45.55% in 2022.
- Rockwell Medical's Total Current Liabilities stood at $17.7 million in 2022, then fell by 5.96% to $16.6 million in 2023, then declined by 15.3% to $14.1 million in 2024, then tumbled by 32.01% to $9.6 million in 2025, then gained by 3.01% to $9.9 million in 2026.
- The last three Total Current Liabilities figures came in at $9.9 million (Q1 2026), $9.6 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | 9.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.87 Mn |
| Dec 31, 2025 | 9.58 Mn |
| Sep 30, 2025 | 9.58 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 11.21 Mn |
| Dec 31, 2024 | 14.09 Mn |
| Sep 30, 2024 | 14.18 Mn |
| Jun 30, 2024 | 14.89 Mn |
| Mar 31, 2024 | 14.95 Mn |
| Dec 31, 2023 | 16.64 Mn |
| Sep 30, 2023 | 21.41 Mn |
| Jun 30, 2023 | 17.45 Mn |
| Mar 31, 2023 | 15.07 Mn |
| Dec 31, 2022 | 17.69 Mn |
| Sep 30, 2022 | 19.34 Mn |
| Jun 30, 2022 | 18.54 Mn |
| Mar 31, 2022 | 19.60 Mn |
| Dec 31, 2021 | 20.97 Mn |
| Sep 30, 2021 | 21.76 Mn |
| Jun 30, 2021 | 34.04 Mn |